BBR Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $412K | Sell |
8,890
-1,022
| -10% | -$47.3K | 0.03% | 158 |
|
|
2025
Q1 | $605K | Hold |
9,912
| – | – | 0.04% | 120 |
|
|
2024
Q4 | $561K | Sell |
9,912
-1,006
| -9% | -$56.9K | 0.04% | 136 |
|
|
2024
Q3 | $565K | Sell |
10,918
-171
| -2% | -$8.85K | 0.04% | 124 |
|
|
2024
Q2 | $461K | Sell |
11,089
-899
| -7% | -$37.3K | 0.04% | 116 |
|
|
2024
Q1 | $650K | Buy |
11,988
+1,079
| +10% | +$58.5K | 0.05% | 124 |
|
|
2023
Q4 | $560K | Sell |
10,909
-441
| -4% | -$22.6K | 0.06% | 98 |
|
|
2023
Q3 | $659K | Buy |
11,350
+362
| +3% | +$21K | 0.07% | 81 |
|
|
2023
Q2 | $703K | Sell |
10,988
-224
| -2% | -$14.3K | 0.08% | 83 |
|
|
2023
Q1 | $777K | Sell |
11,212
-689
| -6% | -$47.8K | 0.09% | 78 |
|
|
2022
Q4 | $856K | Hold |
11,901
| – | – | 0.1% | 81 |
|
|
2022
Q3 | $846K | Sell |
11,901
-3,328
| -22% | -$237K | 0.11% | 79 |
|
|
2022
Q2 | $1.17M | Hold |
15,229
| – | – | 0.14% | 69 |
|
|
2022
Q1 | $1.11M | Buy |
15,229
+9,087
| +148% | +$664K | 0.1% | 85 |
|
|
2021
Q4 | $383K | Buy |
6,142
+1,834
| +43% | +$114K | 0.05% | 137 |
|
|
2021
Q3 | $255K | Sell |
4,308
-545
| -11% | -$32.3K | 0.02% | 190 |
|
|
2021
Q2 | $324K | Buy |
4,853
+150
| +3% | +$10K | 0.03% | 147 |
|
|
2021
Q1 | $297K | Buy |
4,703
+1,283
| +38% | +$81K | 0.02% | 166 |
|
|
2020
Q4 | $212K | Buy |
3,420
+92
| +3% | +$5.7K | 0.02% | 175 |
|
|
2020
Q3 | $201K | Buy |
+3,328
| New | +$201K | 0.02% | 172 |
|